Stockreport

Mitsubishi Tanabe Pharma America Celebrates Second Anniversary of RADICAVA ORS® (edaravone) Launch in the U.S. [Yahoo! Finance]

MITSUBISHI CH GRP U/ADR  (MTLHY) 
NASDAQ:AMEX Investor Relations: mitsubishichem-hd.co.jp/english/ir
PDF Since its availability in June 2022 , RADICAVA ORS has been used to treat over 9,600 people living with amyotrophic lateral sclerosis (ALS). "Helping people who are li [Read more]